Safer aortic crossclamping during short-term moderate hypothermic circulatory arrest for cardiac surgery in patients with a bad ascending aorta  by Takami, Yoshiyuki et al.
Takami et al Acquired Cardiovascular Disease
A
C
DSafer aortic crossclamping during short-term moderate hypothermic
circulatory arrest for cardiac surgery in patients with a bad ascending
aorta
Yoshiyuki Takami, MD, Kazuyoshi Tajima, MD, Sachie Terazawa, MD, Noritaka Okada, MD, Kei Fujii, MD, and
Yoshimasa Sakai, MD
Objective: Cardiac surgery in patients with severely atherosclerotic or porcelain ascending aorta is technically
challenging, with markedly increased risk of atheroembolism.We describe a technique of meticulous crossclamp-
ing of a difficult aorta during short-term moderate hypothermic circulatory arrest.
Methods: From 1997 to 2007, we found 40 patients (mean age, 70  8 years), including 14 patients undergoing
hemodialysis, whose preoperative computed tomographic and intraoperative epiaortic ultrasonographic scans re-
vealed eggshell calcification (n ¼ 15) or protruding atheromas (n ¼ 25) of the ascending aorta. They underwent
cardiac surgery (aortic, 31 patients; mitral, 3 patients; both, 5 patients; and coronary alone, 1 patient) by means of
meticulous crossclamping during hypothermic circulatory arrest for 3.4  1.5 minutes at a rectal temperature of
29.0C 2.3C. During hypothermic circulatory arrest, we performed only internal inspection to identify the safe
location of crossclamping in 21 patients, whereas we required debridement of calcification or atheroma by using
the Cavitron Ultrasonic Surgical Aspirator (Tyco Healthcare, Mansfield, Mass) for safe crossclamping in 19
patients.
Results: By using this technique, no patients died during the hospital stay. Stroke occurred in 1 (2.5%) patient,
and transient agitation occurred in 1 patient. Re-exploration for bleeding was required in 1 patient, and wound
infection occurred in 2 patients. During follow-up, with a median time of 5.2 years, the overall survival rates
were 100%, 90%, and 76% at 1, 3, and 5 years, respectively. Three patients required reoperations during the
follow-up period because of pseudoaneurysm in 2 patients and prosthetic valve infection in 1 patient.
Conclusion: Short-term moderate hypothermic circulatory arrest is quite useful for safe aortic crossclamping af-
ter internal inspection or debridement in high-risk patients with a severely atherosclerotic aorta.Atherosclerotic disease of the ascending aorta is an impor-
tant cause of stroke and embolic events after cardiac sur-
gery.1-3 Aortic crossclamping is associated with
a substantial release of particulate matter that has embolic
potential.4,5 This problem is increasingly encountered in
the current practice of adult cardiac surgery, especially in el-
derly patients and those undergoing hemodialysis. Isolated
coronary artery bypass grafting (CABG) can be done with-
out aortic manipulation. Mitral and tricuspid valve surgery
can be performed without aortic crossclamping, sometimes
with hypothermic fibrillation. However, patients who re-
quire aortic valve surgery cannot be managed with these
techniques. Surgical strategies in such patients with a se-
verely diseased ascending aorta include apicoaortic con-
duit,6 endoaortic balloon occlusion,7 aortic valve
replacement (AVR) during profound hypothermic circula-
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doi:10.1016/j.jtcvs.2008.09.022The Journal of Thoracic andtory arrest (HCA),8 and local endarterectomy or total re-
placement of the ascending aorta during HCA to allow for
the safe placement of a crossclamp followed by AVR.9,10
Unfortunately, the stroke rate, morbidity, and mortality are
still high with these aggressive strategies. Considering that
a less aggressive strategy is adequate in such high-risk pa-
tients with significant comorbidities, we have established
a technique of meticulous aortic crossclamping during
short-term moderate HCA followed by cardiac procedures.
The purpose of this retrospective study is to report the results




From January 1997 to December 2007, 40 patients were referred for car-
diac surgery in the setting of atherosclerotic plaques (n ¼ 25, Figure 1) or
eggshell calcification (n ¼ 15, Figure 2) of the ascending aorta. They
were 2.4% of 1645 adult patients who underwent cardiac surgery during
the period in our institute. Their demographic data are listed in Table 1.
Mean age was 70  8 years (range, 44–83 years), and 55% were men. Se-
venty-six percent had pure aortic stenosis, and 14% had mixed aortic steno-
sis and regurgitation. Forty percent had coronary artery disease, and 20%
had mitral valve disease. Fourteen (35%) patients were receiving regular
hemodialysis because of end-stage renal failure. One patient had a previous
cardiac operation: CABG. All patients had preoperative evaluation of their
entire thoracic aorta with computed tomographic scanning to examine the
possible site of cannulation and crossclamping.Cardiovascular Surgery c Volume 137, Number 4 875




AVR ¼ aortic valve replacement
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
CUSA ¼ Cavitron Ultrasonic Surgical Aspirator
HCA ¼ hypothermic circulatory arrest
Operative Procedures
After standard anesthetic preparation, a median sternotomy was per-
formed to expose the ascending aorta and the heart. The diagnosis of porce-
lain aorta, which had been detected on the preoperative computed
tomographic scans, was confirmed by means of digital palpation of the
aorta. The aorta was then examined by using epiaortic ultrasonographic
scanning. Epiaortic scanning was performed with a 7.5-MHz linear ultra-
sonic probe coated with ultrasonic gel packed in a sterile plastic sleeve.
The scanning was first performed before opening the pericardium to sustain
an echolucent window for optimal visualization of the anterior ascending
aortic wall. The scanning was again performed after opening the pericar-
dium to determine whether the protruding atheromatous plaque or mobile
atheromawas present in the proposed region of cannulation and crossclamp-
ing. The patients with patchy calcification or atheroma plaques, in whom
simply moving the crossclamp away from the involved sites sufficed,
were excluded from this study cohort.
Aortic cannulation was the preferred site if a plaque-free and soft area
was identified. Alternatively, the axillary or femoral arteries were used,
and femoral cannulation was the last choice. The right atrium was cannu-
lated directly for venous drainage, whereas bicaval cannulations were
used in mitral valve surgery, and a common femoral venous cannulation
of the right atrium was used in reoperations. Patients were then started on
cardiopulmonary bypass (CPB) and cooled to a rectal temperature of ap-
proximately 30C (an esophageal temperature of approximately 28C). A
left ventricular vent was inserted through the right superior pulmonary
vein. Once the appropriate temperature was reached, HCA was initiated
with the patient in a steep Trendelenburg position. During HCA, the aortic
cannula was clamped to avoid filling with air, the ascending aorta was
opened in the line for AVR and not transected, and retrograde cold blood
cardioplegia was administered. When the ascending aorta was inspected
from inside and a suitable site for crossclamping was identified under direct
vision, the aorta was crossclamped carefully, with blood flushed by means
of retrograde cerebral perfusion by keeping the central venous pressure at
approximately 20 mm Hg, followed by restart of perfusion through the aor-
tic cannula. In patients with porcelain aorta, protruding plaques, or mobile
atheroma, the subsequent crossclamp site was carefully cleared by means of
debridement or endarterectomy with the Cavitron Ultrasonic Surgical Aspi-
rator (CUSA; Tyco Healthcare, Mansfield, Mass). The debridement or end-
arterectomy was performed until the inner surface of the aorta to be clamped
was judged to be smooth and soft. After washout by means of retrograde ce-
rebral perfusion and disappearance of the floating debris or particles on the
blood, circulation was restarted by slowly expelling air and debris from the
ascending aorta, and the endarterectomized aorta was crossclamped. Once
the aorta was crossclamped, full flow was resumed, rewarming was started,
and the intracardiac procedures were performed. During this phase, myocar-
dial protection was achieved by means of antegrade direct coronary ostial
injection or retrograde coronary sinus delivery. Finally, the aorta was closed
with double 4–0 polypropylene sutures, with or without Teflon felt strips.
Data Analysis
This study was approved by the institutional review board of our hospi-
tal. Clinical, procedural, and postoperative data were collected for this ret-
rospective review. Deaths occurring at any time during the hospital stay or876 The Journal of Thoracic and Cardiovascular Suanywhere within 30 days since surgical intervention were categorized as
early deaths. Stroke was defined as a prolonged (>72 hours) or permanent
neurologic deficit not present preoperatively and persisting at the time
of discharge. It is usually associated with abnormal results of magnetic re-
sonance imaging or computed tomographic scans. Nonfocal neurologic
derangements, such as confusion and psychosis, were recorded as
neurocognitive defects. Neurologic assessment was performed by consul-
ting neurologists, if necessary. Follow-up telephone interviews were con-
ducted by the authors early in April 2008. Descriptive statistics were
expressed as the mean standard deviation. Kaplan–Meier survival curves
were developed with StatView 5.0 software (Abacus Concepts, Inc, Berke-
ley, Calif).
RESULTS
Amajority of 40 study patients underwent AVR (n¼ 36),
as demonstrated in Table 2. Among the patients who under-
went AVR, 38% had mechanical valves, and 62% had bio-
prostheses. The mechanical valves implanted included the
CarboMedics (CarboMedics, Inc, Austin, Tex) 21-mm
(n ¼ 2) and 23-mm (n ¼ 1) valves; the ATSAP (ATS Med-
ical, Inc, Minneapolis, Minn) 18-mm (n ¼ 4) and 22-mm
(n¼ 1) valves; the Bicarbon 21-mm valve (n¼ 3; Sorin Bio-
medica Cardio, Saluggia, Italy); the OnX (Medical Carbon
Research Institute, LLC, Austin, Tex) 19-mm (n ¼ 1) and
21-mm (n ¼ 2) valves; and the St Jude Medical regent 17-
mm valve (n ¼ 1; St Jude Medical, Inc, Minneapolis,
Minn). The tissue valves implanted were the Hancock (Med-
tronic, Inc, Minneapolis, Minn) 21-mm (n ¼ 1), 23-mm
(n ¼ 1), and 25-mm (n ¼ 1) valves; the Mosaic (Medtronic,
Inc) 23-mm (n¼ 4) and 25-mm (n¼ 1) valves; and the Car-
pentier-Edwards Pericardial (CEP; Baxter Healthcare Corp,
Newport Beach, Calif) 19-mm (n ¼ 11), 21-mm (n ¼ 4),
and 23-mm (n ¼ 2) valves. Aortic prostheses of less than
23 mm were implanted in 75% of the patients undergoing
FIGURE 1. An intraoperative epiaortic ultrasonographic scan in a 70-year-
old female patient who underwent aortic valve replacement with a 19-mm
Carpentier–Edwards Pericardial valve. Thick aortic intima over 2 mm and
protruding atheroma are shown, suggesting the aorta is not unclampable.rgery c April 2009
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DFIGURE 2. Computed tomographic scans before and after the operation in a 76-year-old man undergoing chronic hemodialysis for 18 years who underwent
aortic valve replacement with annular dilatation with a 21-mm Carpentier–Edwards Pericardial valve. The diffuse calcification is specific to the patients un-
dergoing hemodialysis, sometimes referred to a Monckeberg’s sclerosis. The calcified plaques inside the aorta were removed with the Cavitron Ultrasonic
Surgical Aspirator to make the aorta safe for crossclamping. The image shows that the volume of calcifications is decreased by the surgical maneuver.AVR. Fifteen percent of the patients undergoing AVR re-
quired annular enlargement with a commercially available
bovine or equine pericardium to obtain an effective orifice
area of greater than 0.85 cm2/m2 and to avoid patient-pros-
thesis mismatch. Forty-two percent of patients undergoing
AVR required additional CABG, with in situ arterial grafts
only in 6 patients, saphenous vein grafts only in 3 patients,
and both grafts in 6 patients. For CPB, as shown in Table
3, the ascending aorta was cannulated in 70% of patients,
whereas 30% required alternative sites (axillary artery,
10%; femoral artery, 20%). The patients reached a rectal
temperature of 29.0C  2.3C and an esophageal tempera-
ture of 26.5C 2.6C by means of systemic cooling for 15
 8 minutes. No patients required a period of HCA for lon-
ger than 7.5 minutes, with a mean of 3.4 1.5 minutes. Dur-
ing HCA, only inspection of the aorta from the inside was
performed to identify a suitable site for crossclamping in
21 (53%) patients, whereas additional debridement of calci-The Journal of Thoracic andfication, protruding plaque, or mobile atheroma with CUSA
was required in 19 (47%) patients. The CPB duration and
aortic crossclamp time averaged 228  67 and 131  51
minutes, respectively.
No patients died during the hospital stay. Postoperative
hospital stay averaged 31  38 days. The hospital stays of
3 patients undergoing hemodialysis were greater than 50
days (71 days, 163 days, and 199 days). Two of them had
postoperative sternomediastinitis, which was fortunately
cured completely. One patient had recurrent pleural effu-
sion, resulting in longer hospital stay. When these patients
were excluded, the mean hospital stay was 20  8 days.
Postoperative complications are highlighted in Table 4.
There was 1 patient with a central neurologic complication,
whose dysarthria and mild right hemiparesis were evident 2
days after AVR with a Mosaic 25-mm valve. In this patient
the ascending aorta was crossclamped after inspection dur-
ing HCA for 6 minutes at an esophageal temperature ofCardiovascular Surgery c Volume 137, Number 4 877
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D26C. Transient agitation and psychosis of milder degree
was noted in only 1 patient. Re-exploration for bleeding
was performed in 1 patient after reoperative AVR with
a CEP 19-mm valve, in whom the sutures of annular enlarge-
ment with an equine pericardial patch was a bleeding site.
Although 40% of patients required CABG, no patients
had a documented perioperative myocardial infarction or
low cardiac output necessitating circulatory assist.
Follow-up was obtained in all patients at a median interval
of 5.2 years after surgical intervention (3.6  2.4 years;
range, 57 days–10.4 years). Six late deaths occurred at 1.1,
1.7, 2.0, 3.2, 5.0, and 4.4 years because of cerebral infarc-
tion, gastrointestinal perforation, heart failure, bladder can-
cer, hepatoma, and pneumonia, respectively, leading to
TABLE 1. Demographics for 40 study patients
No. (%) or mean ± SD (range)
Mean age (y) 70  8 (44–83)
Male/female sex 22/18




Diabetes mellitus 9 (23%)
Previous myocardial infarction 10 (25%)
Previous cerebrovascular accident 2 (5%)
Previous cardiac surgery 1 (2.5%)
Hemodialysis 14 (35%)
Duration (y) 13  7 (3–23)






SD, Standard deviation; NYHA, New York Heart Association.
TABLE 2. Surgical procedures
No. (%)
Procedure





AVR with annular enlargement 6/36 (17%)
Aortic prosthesis
Mechanical/bioprosthetic 15/21 (38%/62%)
Size<23 mm 30 (75%)





Urgent or emergency 2 (5%)
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting; MVR, mitral
valve replacement; MVP, mitral valve plasty; CEP, Carpentier-Edwards Pericardial.878 The Journal of Thoracic and Cardiovascular Suoverall survivals of 100%, 90%, and 76% at 1, 3, and 5
years, respectively (Figure 3). Three patients required reop-
erations during the follow-up period because of pseudoa-
neurysm in 2 patients and prosthetic valve infection in 1
patient. The pseudoaneurysm was observed at the suture
line of the aortic patch, and the reoperations (ie, replacement
of the ascending aorta) were performed 8 months and 44
months after the operation, respectively. The prosthetic
valve infection was observed in a 66-year-old patient 5
months AVR and mitral valve replacement. All patients un-
dergoing reoperations survived and remain alive.
DISCUSSION
Cerebral complications result in not only increased perio-
perative morbidity and mortality but also poor long-term
prognosis after surgical intervention.3 Although the patho-
physiology of stroke is multifactorial, we have to pay atten-
tion to cerebral microemboli during the operation. Several
studies identified an association between the degree of ather-
oma in the ascending aorta and new brain ischemic
TABLE 3. Intraoperative data
No. (%) or mean ± SD (range)
Arterial cannulation
Ascending aorta 28 (70%)
Axillary artery 4 (10%)
Femoral artery 8 (20%)
Moderate hypothermia
Lowest esophageal temperature (C) 26.6  2.6 (22–31)
Lowest rectal temperature (C) 29.0  2.3 (25–33)
Circulatory arrest (min) 3.4  1.5 (1.0–7.5)
Manipulation of aorta
Inspection only 23 (58%)
Debridement with CUSA 17 (42%)
Cardiopulmonary bypass (min) 228  67 (147–470)
Aortic crossclamp time (min) 131  51 (81–341)
SD, Standard deviation; CUSA, Cavitron Ultrasonic Surgical Aspirator.
TABLE 4. Postoperative morbidity and mortality
No. (%) or mean ± SD (range)
In-hospital death 0
Hospital stay (d) 31  38 (9–199)
Stroke 1 (2.5%)
Nonfocal neurologic derangement 1 (2.5%)
Re-exploration for bleeding 1 (2.5%)
IABP/low cardiac output 0
Perioperative myocardial infarction 0
Intubation>48 h 4 (10%)
ICU stay>2 d 5 (12.5%)
Wound infection 2 (5%)
Bowel disease 2 (5%)
Permanent pacemaker 0
Delayed reoperation
Aortic pseudoaneurysm 2 (5%)
Prosthetic valve endocarditis 1 (2.5%)
SD, Standard deviation; IABP, intra-aortic balloon pumping; ICU, intensive care unit.rgery c April 2009
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a review article, the stroke incidence appears to be increasing
because more high-risk patients currently undergo cardiac
surgery, such as patients undergoing hemodialysis, whose
vascular atherosclerosis is highly prevalent.13-15 In our pa-
tients 35% were undergoing hemodialysis. Calcification
around atherosclerotic lesions increases plaque fragility,
which in turn makes that part of the vessel wall more vulner-
able to shear stresses, precipitating embolic complications
after cardiac surgery, as focused on in the present study.
Two distinct pathologic patterns of calcification are recog-
nized.15 The first form is intimal calcification in the context
of atherosclerotic plaque formation with lipid-laden form
cells. This process is focal, and adjacent regions of the vessel
wall might be normal. The second form of calcification is
diffuse mineral deposition throughout the vascular tree,
sometimes referred to a Monckeberg’s sclerosis, as shown
in Figure 2. This form of calcification occurs predominantly
in the media of the vessel, with no relationship to atheroma-
tous plaque formation. This is a striking feature of vascular
disease seen in patients undergoing hemodialysis.
There have been several reports of surgical strategy to
decrease manipulation of the unclampable aorta in cardiac
surgery, as summarized by Zingone and colleagues.16 An
approach using an endoluminal occluding balloon was dem-
onstrated to be ineffective and associated with a significantly
higher risk of in-hospital death and stroke.7 Deep HCA
(<20C) emerges as a core method to approach the difficult
aorta during aortic valve surgery strictly requiring an aortot-
omy. The simplest approach appears to be AVR during deep
HCAwithout aortic crossclamping. However, this technique
was associated with high mortality and stroke rates of greater
than 10%.9,10 An alternative approach is aortic endarterec-
tomy during deep HCA proceeding to aortic crossclamp-
ing.9,10 A more radical option is graft replacement of the
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FIGURE 3. Kaplan–Meier estimate of overall survival.The Journal of Thoracic andbeen varied with a relatively lower stroke rates but a rela-
tively high mortality rate.8-10
We are reluctant to use deep HCA as seen in previous re-
ports because the patients with difficult aortas are at quite
high risk and carry significant comorbidities. In particular,
the patients undergoing hemodialysis experience malnutri-
tion (low serum albumin), inflammation, and atherosclerosis
syndrome, which are associated with all-cause and cardio-
vascular mortality.17 Therefore we have adopted moderate
HCA (28C to 30C) to simply perform aortic inspection
or endarterectomy for safe aortic crossclamping in such
high-risk patients. The maneuvers were intended to be as
short and simple as possible. Compared with previous re-
ports, the lowest temperature was much higher and the dura-
tion of HCA was much shorter in our study. We simply
applied retrograde cerebral perfusion for brain protection
during HCA, minimizing the risk of debris and air embo-
lism. Although the approach has been simplified, both mor-
tality and stroke rate in our study were superior to those seen
in previous reports. In addition, we think that epiaortic ultra-
sonographic scanning is insufficient to guide safer clamp re-
placement and to determine whether the lesion should be
endarterectomized. Direct inspection and aortic crossclamp-
ing under direct vision are more reliable and safer.
During moderate HCA, we proceeded with aortic endar-
terectomy or debridement, when needed, before safe aortic
crossclamping. The atheromas with mobile components or
calcified plaque were resected with the CUSA to make the
aorta safe for clamping. One of the contributing factors to
the lower mortality and stroke rate seen in our study might
be the use of the CUSA. The CUSA is one of the most pop-
ular devices that facilitate bloodless liver transection.18 It
uses a vibrating metal tip to fragment tissue and then aspi-
rates the debris through the hollow center of the tip.19 It
has been also used in cardiac surgery, especially to remove
valve annular calcification.20 Figure 2 demonstrates the
comparison of the computed tomographic scans before and
after the operation in a 76-year-old man undergoing chronic
hemodialysis for 18 years who underwent AVRwith annular
dilatation with a 21-mmCEP valve. The calcified plaques in-
side the aorta were removed by using the CUSA to make the
aorta safe for crossclamping. Figure 2 revealed that the vol-
ume of calcifications was decreased by using the surgical
maneuver. Although our technique is effective for safer aor-
tic crossclamping, we should pay attention to the fate of the
endarterectomized aorta. In our patient cohort, 2 patients re-
quired reoperations during the follow-up period because of
pseudoaneurysm formation. In both patients the pseudoa-
neurysm was observed at the suture line of the patch used
for aortic annular enlargement and was also associated
with infection. We should recognize the fragility of the aor-
tic wall endarterectomized with the CUSA as a risk factor for
pseudoaneurysm formation, and therefore we have to rein-
force the aortic suture line carefully during the operation.Cardiovascular Surgery c Volume 137, Number 4 879




Although conclusions from any nonrandomized, retro-
spective analysis of a small cohort of patients should be in-
terpreted with caution, our technique of meticulous aortic
crossclamping after internal inspection, endarterectomy, or
both with the CUSA during short-term moderate HCA is
useful to minimize the mortality and stroke rate in high-
risk patients with a difficult ascending aorta.
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